APA (7th ed.) Citation

Sorkhabi, A. D., ZareDini, M., Fazlollahi, A., Sarkesh, A., Naseri, A., Mousavi, S. E., . . . Safiri, S. (2023). The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: A systematic review of clinical trials. BMC.

Chicago Style (17th ed.) Citation

Sorkhabi, Amin Daei, et al. The Safety and Efficacy of Tislelizumab, Alone or in Combination with Chemotherapy, for the Treatment of Non-small Cell Lung Cancer: A Systematic Review of Clinical Trials. BMC, 2023.

MLA (9th ed.) Citation

Sorkhabi, Amin Daei, et al. The Safety and Efficacy of Tislelizumab, Alone or in Combination with Chemotherapy, for the Treatment of Non-small Cell Lung Cancer: A Systematic Review of Clinical Trials. BMC, 2023.

Warning: These citations may not always be 100% accurate.